Results 181 to 190 of about 7,196 (214)
Depression and clinical progression in spinocerebellar ataxias [PDF]
BACKGROUND: Depression is a common comorbidity in spinocerebellar ataxias (SCAs) but its association with ataxia progression is not well understood. OBJECTIVES: To study the prevalence and influence of depressive symptoms in SCAs. METHODS: We studied 300
Raymond Y Lo +2 more
exaly +2 more sources
Movement disorders in spinocerebellar ataxias
Universidade Federal de São Paulo, Dept Neurol & Neurosurg, Div Gen Neurol & Ataxias, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Neurol & Neurosurg, Div Gen Neurol & Ataxias, São Paulo, BrazilWeb of ...
Judith van Gaalen, Paola Giunti
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Spinocerebellar ataxias: an update
Current Opinion in Neurology, 2007Here we discuss recent advances regarding the molecular genetic basis of dominantly inherited ataxias.Important recent observations include insights into the mechanisms by which expanded polyglutamine causes cerebellar degeneration; new findings regarding how noncoding expansions may cause disease; the discovery that conventional (i.e.
Bing-wen, Soong, Henry L, Paulson
openaire +2 more sources
The electrophysiology of spinocerebellar ataxias
Neurophysiologie Clinique/Clinical Neurophysiology, 2016Spinocerebellar Ataxias (SCAs) are a group of autosomal dominantly inherited neurodegenerative diseases, involving the cerebellum and the brainstem. Genetic testing is the most important method of diagnosis. Nowadays, nearly 40 types of SCAs have been identified by genetic analysis.
Lipin, Liang, Tao, Chen, Yan, Wu
openaire +2 more sources
Spinocerebellar ataxias in Asia: Prevalence, phenotypes and management
Parkinsonism and Related Disorders, 2021Teije H Van Prooije +2 more
exaly
Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
Expert Opinion on Therapeutic Targets, 2020Andreia Neves-Carvalho +2 more
exaly

